Cargando…
Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer
SIMPLE SUMMARY: New biomarkers are needed for biliary tract cancer. Here, we tested the prognostic value of 89 circulating proteins. Protein levels were measured in blood samples from four groups of patients treated for biliary tract cancer with either chemotherapy or surgery. Using data from the fi...
Autores principales: | Christensen, Troels D., Madsen, Kasper, Maag, Emil, Larsen, Ole, Jensen, Lars Henrik, Hansen, Carsten P., Markussen, Alice, Høgdall, Dan T. S., Chen, Inna M., Nielsen, Dorte, Johansen, Julia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953893/ https://www.ncbi.nlm.nih.gov/pubmed/36831406 http://dx.doi.org/10.3390/cancers15041062 |
Ejemplares similares
-
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
por: Christensen, Troels D., et al.
Publicado: (2022) -
Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay
por: Christensen, Troels D., et al.
Publicado: (2022) -
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer
por: Lindgaard, Sidsel C., et al.
Publicado: (2022) -
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
por: Lindgaard, Sidsel C., et al.
Publicado: (2022) -
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II Trial
por: Markussen, Alice, et al.
Publicado: (2020)